Seth van Voorhees - 15 Jun 2021 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Reporting relationship: Chief Financial Officer
Issuer ticker: PDSB
Reported as of: 15 Jun 2021
Net transaction value: +$150,000
SEC form: 4
Accepted by SEC: 17 Jun 2021, 18:52:14 UTC
Next SEC filing: 29 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Seth Van Voorhees

Key filing fact

Seth van Voorhees filed Form 4 for PDS Biotechnology Corp (PDSB) on 17 Jun 2021.

Key facts

This page summarizes Seth van Voorhees's Form 4 filing for PDS Biotechnology Corp (PDSB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Jun 2021, 18:52.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$150,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PDSB transaction

Common Stock

Purchase

Transaction value: $150,000
Shares: +17,647
Change %
Price: $8.50
Shares after: 17,647
Date: 15 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021.